Electrospinning teabag nano scaffold
An Oxford-based company is developing a nanofibre device that would allow new insulin cells to be implanted and take away the need for daily insulin injections.
Clinical biomaterials company, Electrospinning, is working on the device that resembles a teabag but, instead of tea leaves, it would store insulin-producing pancreatic beta cells — protecting them from being destroyed — while allowing insulin molecules to be released into the body as needed.
It is at least two years from any real human use, but could transform the way diabetes is managed.
Read about it in detail on Sifted.
